- Home
- AUPH vs HDL Comparison
AUPH vs HDL Comparison
Compare AUPH & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | HDL |
|---|---|---|
| Founded | 1993 | 2016 |
| Country | Canada | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 988.5M |
| IPO Year | 1999 | 2024 |
Fundamental Metrics
Financial Performance| Metric | AUPH | HDL |
|---|---|---|
| Price | $14.87 | $16.49 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 994.1K | 1.9K |
| Earning Date | 02-26-2026 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.55 | 0.04 |
| Revenue | $265,808,000.00 | ★ $820,865,000.00 |
| Revenue This Year | $21.76 | $10.64 |
| Revenue Next Year | $16.45 | $13.63 |
| P/E Ratio | ★ $27.00 | $52.81 |
| Revenue Growth | ★ 20.62 | 8.02 |
| 52 Week Low | $6.55 | $15.83 |
| 52 Week High | $16.54 | $28.88 |
Technical Indicators
Market Signals| Indicator | AUPH | HDL |
|---|---|---|
| Relative Strength Index (RSI) | 40.90 | 46.38 |
| Support Level | $14.74 | $15.83 |
| Resistance Level | $15.28 | $17.56 |
| Average True Range (ATR) | 0.50 | 0.16 |
| MACD | -0.13 | 0.04 |
| Stochastic Oscillator | 7.25 | 38.15 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.